Profile cover photo
Profile photo
Brainreader ApS
Cutting edge medical software technology
Cutting edge medical software technology

Brainreader ApS's posts

Post has attachment
The latest publication on Brainreader's software, Neuroreader, is available now.

Predictive Utility of Marketed Volumetric Software Tools in Subjects at Risk for Alzheimer Disease: Do Regions Outside the Hippocampus Matter?

By T.P. Tanpitukpongse, M.A. Mazurowski, J. Ikhena, J.R. Petrella, for the Alzheimer's Disease Neuroimaging Initiative

Post has attachment
Follow the latest Journal of Alzheimer's blog by DR. Cyrus Raji as he highlight the need for improved diagnosis of memory disorders and talks Applying Quantitative Neuroimaging in Cognitive Decline and Alzheimer’s.

Post has attachment
Follow the link below to read the full interview featuring Brainreader and Dr. Cyrus Raji, neuroradiology fellow at the University of California San Francisco.

Learn how Neuroreader software is such a vital assessment tool and can be used to diagnose Alzheimer's and degenerative brain diseases in pre-symptom stages.

Post has attachment
Using Neuroreader for analyzing MRI scans, UCLA researchers Raji and Merrill detected the shrinkage of several key brain regions in a former football player with cognitive problems. Follow the link below to read the press release from UCLA.

Post has attachment
Welcome to Brainreader

Through our work we aim to provide cutting edge medical technology for everyone.

We strive to increase the use of medical image processing software, allowing healthcare professionals around the world to access structural MRI's in a faster, more specific and more objective way

- all for the benefit of the medical world and the patients out there.

Post has attachment
We will be attending the upcoming ASNR conference in Washington and will be pleased to meet you there.

If you are interested in meeting us and learning more about how Neuroreader™ can make a difference in your daily practice, please do not hesitate to book a meeting.

Post has attachment
Researchers have long recognised a relationship between Type 2 diabetes and Alzheimer’s. Glucose metabolism is one of several disease “markers” with the brain unable to utilise sugar as it takes hold.

The breakthrough at Aarhus University in Denmark has now inspired the start of major UK trials which have left neuroscientists at Imperial College London “really excited”.

Post has attachment
We are extremely proud and excited to share with you the latest news on NEUROREADER™.

Based on its recent study of the brain volumetric image analysis market, Frost & Sullivan recognises Brainreader ApS with the 2016 European Frost & Sullivan Award for Enabling Technology Leadership.

Post has attachment
We are proud and excited to share with you a recent publication of a study for improving cognitive function and increasing the volume of the hippocampus in elderly with MCI, in which Neuroreader has been cited, saying:

"Applying Neuroreader in clinical practice for prevention purposes such as described in this paper is part of a larger goal of utilizing quantitative neuroimaging in brain aging and cognitive decline."

Post has attachment
Care facilities are increasingly using sight, sound and other sensory cues to stimulate memories in people with Alzheimer's and other forms of dementia. One Pa. facility uses 1940s-themed rooms, and music to take residents back in time.
Wait while more posts are being loaded